Amgen cuts price of cholesterol drug by almost 60%, echoing rival's move
October 24, 2018 at 16:01 PM EDT
Biotech giant Amgen is lowering the price of its cholesterol medicine Repatha by almost 60 percent, following a similar move from its competitor, after both drugs failed to meet sales expectations.
